Business of Cannabis: Cannabis News | Cannabis Views | Cannabis Trends
by Business of Cannabis
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇨🇦CA · Business News#1515K to 30K
- 🇨🇴CO · Business News#152500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.8K to 17K🎙 Weekly cadence·600 episodes·Last published 9mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
5.5K to 33K🇨🇦91%🇨🇴9% - Active Followers
Loyal subscribers who consistently listen
1.6K to 9.9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Guest Episode 6 | Rethinking Healthcare Leadership: Purpose-Driven Practice in Action - Releaf x Professor Chris Shambrook
Aug 11, 2025
Unknown duration
Guest Episode 5 | From Anecdote to Evidence: Using Data for Advanced Access - Releaf x Dr. Anne Katrin Schlag
Jul 9, 2025
Unknown duration
Guest Episode 3 | From Law to Limbo: The Broken Promise of UK Medical Cannabis (Releaf x Fieldfisher LLP)
May 27, 2025
Unknown duration
Guest Episode 2 | Releaf x Glass Pharms
Mar 25, 2025
Unknown duration
Episode 14 | An Inside Look into the Historic Netherlands Market
Jan 14, 2025
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 8/11/25 |  Guest Episode 6 | Rethinking Healthcare Leadership: Purpose-Driven Practice in Action - Releaf x Professor Chris Shambrook | What does purpose-driven leadership look like inside a fast-growing medical cannabis clinic? In this special edition of the Business of Cannabis Podcast, Tim Kirby, CEO of Releaf, sits down with Professor Chris Shambrook, renowned performance psychologist and long-time advisor to the British Olympic rowing team. Together, they unpack how high-performance principles drawn from elite sport can translate into more intentional, human-centred healthcare leadership. From scaling teams with clarity to balancing compliance with compassion, this episode explores how Releaf is redefining what good leadership looks like in modern medicine — and why purpose can’t be an afterthought when the stakes are this high. Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events. This channel highlights the cannabis companies, cannabis brands, cannabis leaders and cannabis trends driving the global sector. | — | ||||||
| 7/9/25 |  Guest Episode 5 | From Anecdote to Evidence: Using Data for Advanced Access - Releaf x Dr. Anne Katrin Schlag | In this special edition of the Business of Cannabis Podcast, we go From Anecdote to Evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf. Together, they explore how the UK can move from anecdotal patient stories to robust, real-world evidence — and why this shift is vital for expanding safe, trusted access to cannabis-based medicines. They unpack how clinics like Releaf are investing in quality-of-life surveys and data-driven patient care, what this means for regulators like NICE, and whether more solid evidence can finally open doors with the BMA, Royal Colleges and wider healthcare system. For anyone interested in how data and patient outcomes can unlock the next stage of UK medical cannabis, this is a conversation not to miss. | — | ||||||
| 5/27/25 |  Guest Episode 3 | From Law to Limbo: The Broken Promise of UK Medical Cannabis (Releaf x Fieldfisher LLP) | The third in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and Robert Jappie, Partner Fieldfisher’s Regulatory Group. Tim and Robert discuss Together, they explore the disconnect between the UK’s 2018 rescheduling of medical cannabis and the lack of meaningful access for patients today. Robert outlines the legal and regulatory hurdles that continue to obstruct progress, while Tim highlights the everyday impact these roadblocks have on clinics and patients. The episode also delves into the rise of self-medication and the persistent use of illicit sources. Tim and Robert examine the factors behind this trend, from affordability and education to stigma and patient trust, despite the existence of a legal framework. Finally, they unpack the complex compliance landscape for cannabis clinics in the UK. From advertising restrictions to tight prescribing protocols, the conversation reveals how clinics like Releaf build patient trust while navigating a shifting and often restrictive regulatory environment. | — | ||||||
| 3/25/25 |  Guest Episode 2 | Releaf x Glass Pharms | The second in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and James Duckenfield, CEO of Glass Pharms. Tim & James discuss the challenges and progress within the UK's medical cannabis industry since its legalisation in 2018, highlighting the previous stagnation due to various factors including inconsistent supply chains and a lack of a healthcare-focused approach. The discussion emphasises the importance of quality, consistency, and patient outcomes, showcasing how their collaboration aims to provide reliable medical cannabis to patients. They also touch upon the regulatory landscape, the need for better education for doctors, and the potential for significant growth in the UK market by addressing unmet healthcare needs. | — | ||||||
| 1/14/25 | Episode 14 | An Inside Look into the Historic Netherlands Market | This episode was recorded live at Cannabis Europa, 2024. | — | ||||||
| 12/12/24 |  Guest Episode | Releaf x SOMAÍ Pharmaceuticals | Next up we have a special episode with Tim Kirby, Chief Executive Officer with Releaf and Michael Sassano, CEO and Chairman of the Board with SOMAÍ Pharmaceuticals. | — | ||||||
| 10/29/24 |  E13 | Lessons from The Empire State with Vladimir Bautista | This episode was recorded live at Cannabis Europa, 2024. | — | ||||||
| 10/21/24 |  E12 | What it Takes to Sell Successfully in Over 100 International Markets with Kate Holste | Business of Cannabis: Podcast | E11 🎙 Next up we're speaking with Kate Holste, Head of International Sales at Boveda Inc.Kate is an accomplished relationship builder with a strong focus on creating value, driving efficiency, and delivering insightful analysis. With a versatile ability to connect with a diverse range of customer profiles, she brings extensive experience in events and brand management, now leading in packaging and consumer products. Kate excels in discovery, negotiation, account management, and ensuring customer satisfaction. As Head of International Sales at Boveda, she helps global cannabis companies maintain the consistency, safety, and freshness of their dried flower products through innovative 2-way humidity control and premium storage solutions.Join us as our host Shahbaaz Kara-Virani chats with Kate about the future of cannabis and Germany's influence on the global market at Cannabis Europa 2024. Youtube 📹 👉 https://youtu.be/bc8-y5kXBrw#podcast #cannabispodcast #cannabisindustry | — | ||||||
| 10/15/24 |  E11 | The Emerging Ukraine Medical Market with Ohla Stefanishya | This podcast was recorded live at Cannabis Europa 2024. | — | ||||||
| 10/9/24 |  E10 | Curaleaf’s Mission Driven Approach to the European Medical Market with Mikael Sodergren | This podcast was recorded live at Cannabis Europa 2024. | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 10/1/24 |  E9 | The Global Terpene Supply Chain with Andrew Lowitz | This podcast was recorded live at Cannabis Europa 2024. | — | ||||||
| 9/24/24 |  E8 | Brand Building 101 with Amy Weinstein | This podcast was recorded live at Cannabis Europa 2024. | — | ||||||
| 9/16/24 |  E7 | Inside The Mind of a Global Cannabis Venture Capitalist with Helene Servillon | This podcast was recorded live at Cannabis Europa 2024. | — | ||||||
| 9/10/24 |  E6 | Tikun Olam’s Best-in-Class European Medicinal Model with Nikos Beis | This podcast was recorded live at Cannabis Europa 2024. | — | ||||||
| 9/10/24 |  Cannabis Europa 2024 Mainstage E5 | State of Play Session: Ukraine | Recorded live at the Barbican Centre, June 2024. | — | ||||||
| 9/3/24 |  E5 | Cannabis as a Sports Medicine with Pat Cash | This podcast was recorded live at Cannabis Europa, 2024. | — | ||||||
| 9/3/24 |  Cannabis Europa 2024 Mainstage E4 | State of Play Session: Netherlands | Recorded live at the Barbican Centre, June 2024. | — | ||||||
| 8/29/24 |  E4 | The Technology Stack & Leader the Global Cannabis Industry Needs with Chris Violas | This podcast was recorded live at Cannabis Europa, 2024. | — | ||||||
| 8/22/24 |  Cannabis Europa 2024 Mainstage E3 | State of Play Session: Greece | Recorded live at the Barbican Centre, June 2024. | — | ||||||
| 8/20/24 |  E3 | Connecting the Global Community with co-founder of the GCNC, Chris Day | Next up is episode 3, with CEO of Project Evolve and Co-Founder of the GCNC Chris Day. Chris is the co-founder of the Global Cannabis Network Collective and CEO of Project Evolve, with over 25 years of experience in corporate reinvention, small business growth, and marketing excellence. Join us as our host Shahbaaz Kara-Virani chats with Chris about some of the issues the GCNC is tackling today. Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events. This channel highlights the cannabis companies, cannabis brands, cannabis leaders and cannabis trends driving the global sector. www.businessofcannabis.com Twitter: www.twitter.com/bofc_global / www.twitter.com/bofc_europe LinkedIn: www.linkedin.com/company/businessofcannabis Instagram: www.instagram.com/businessofcannabis Facebook: www.facebook.com/bofcmedia Apple: http://bofc.me/applepod Podcasts Online: https://bofc.me/bofclive | — | ||||||
| 8/14/24 |  Cannabis Europa 2024 Mainstage E2 | Curaleaf goes international with Boris Jordan, Executive Chairman of Curaleaf | This fireside discussion offers a deep dive into the expansion plans and business objectives for Curaleaf International; their strategies for entering new global markets, potential regulatory challenges, and how they plan to leverage their position as a leading cannabis company. Join us at Cannabis Europa 2025 www.cannabis-europa.com Keep up to date with the company's vision for global growth, potential partnerships, and innovations in product offerings. Join us for a fireside chat with Curaleaf Executive Chairman, Boris Jordan and Omar Sacirbey, Editor at MJBiz Magazine. | — | ||||||
| 8/9/24 |  Business of Cannabis at Cannabis Europa E2 | From Seed to Sale in Switzerland: with Luc Richner, CEO of Vigia | Episode 2 is here, and this time Luc Richner joins Shahbaaz in the hot seat to chat about his journey, Switzerland and sustainable cannabis business models in the future. If you don't know Luc, he's the CEO and co-founder of Vigia, the company behind the compliance software suite Cannavigia. With over 12 years of experience in building and managing companies across various industries in Europe, the Middle East, and Southeast Asia, it's fair to say he's an accomplished entrepreneur. | — | ||||||
| 8/8/24 |  Cannabis Europa 2024 Mainstage E1 | The impact of cannabis rescheduling: Market implications for Germany and the USA with Arthur De Cordova, CEO of Ziel | This quarter two seismic shifts occurred in the United States and Germany with a common denominator: the DEA advanced the rescheduling of cannabis from a narcotic to a Class III drug in the USA, and Germany completed the rescheduling with passage of the Cannabis Reform Law April 1. However, the implications are different for the two largest cannabis markets. Join us for a fireside chat with Arthur de Cordova, a former Country Manager for AstraZeneca in Europe, and CEO of Ziel. | — | ||||||
| 8/1/24 |  Business of Cannabis at Cannabis Europa E1 | Clear Winners: with Arthur De Cordova, CEO of Ziel | Strap in for Episode 1 of our brand new series, Business of Cannabis: Podcast at Cannabis Europa 2024. Kicking things off, CEO of Ziel, Arthur de Cordova joins our host Shahbaaz Kara at the Barbican Centre during our recent Cannabis Europa event - Europe's gateway to global cannabis and thought leadership. | — | ||||||
| 9/29/23 | Cannabis legislation gains momentum worldwide - things about to get SAFER? | And "Most Significant Expansion’ of Market" coming to New York - 1000 licenses! | — | ||||||
Showing 25 of 600
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.